» Authors » Shiva Samavat

Shiva Samavat

Explore the profile of Shiva Samavat including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 45
Citations 349
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nafar M, Khodadadi I, Kalantari S, Tayebinia H, Karimi J, Samavat S, et al.
Iran J Kidney Dis . 2024 Oct; 18(4):227-235. PMID: 39423096
Introduction: Antibody mediated rejection (AMR) is a major challenge in kidney transplantation and adversely affects allograft survival. Oxidative stress (OS) is implicated in AMR pathogenesis by triggering inflammation, apoptosis and...
2.
Nafar M, Keshtkari S, Ziaie S, Firouzan A, Borumandnia N, Dalili N, et al.
Iran J Kidney Dis . 2024 Jun; 18(3):187-194. PMID: 38904339
Introduction: Tacrolimus is the mainstem of immunosuppressive therapy in kidney transplant patients. It has high intrapatient variability (Tac-IPV), which has been reported to affect graft function by predisposing patients to...
3.
Eslami V, Mousavi S, Irilouzadian R, Baghsheikhi H, Jafari Fesharaki M, Samavat S
PLoS One . 2024 Jun; 19(6):e0302200. PMID: 38843270
Background And Aims: Pericardial effusion (PE) is a prevalent form of pericardial involvement in chronic kidney disease (CKD). This study aims to investigate the clinical and laboratory features associated with...
4.
Asadzadeh R, Nafar M, Ahmadpoor P, Samavat S, Nikoueinejad H, Hosseinzadeh M, et al.
Transpl Immunol . 2023 Jul; 80:101887. PMID: 37451646
Background: Cytomegalovirus (CMV) infections caused by the cytomegalovirus are one of the most common problems in patients after kidney transplant. We examined the association of the relationship between the number...
5.
Samavat S, Masrour H, Ahmadikoomleh A, Khoshdel A, Nafar M, Dalili N, et al.
Iran J Kidney Dis . 2023 Feb; 1(1):54-60. PMID: 36739491
Introduction: The accurate assessment of the pre-donation glomerular filtration rate (GFR) is a crucial step in donor selection. We conducted a prospective cross-sectional study to identify the best equation to...
6.
Hajibaratali B, Amini H, Dalili N, Ziaie S, Anvari S, Keykha E, et al.
Transpl Immunol . 2022 Dec; 76:101772. PMID: 36503165
Introduction: The coronavirus disease 2019 (COVID-19) pandemic has caused significant mortality since late 2019. Patients undergoing kidney transplantation (KT) are prone to COVID-19 due to immunosuppressive drug use and various...
7.
Nafar M, Mostafaloo N, Firouzan A, Poorrezagholi F, Samadian F, Dalili N, et al.
Clin Ther . 2022 Nov; 44(12):1566-1576. PMID: 36402595
Purpose: Studies have found that immunocompromised patients have suboptimal responses to COVID-19 vaccines, leading to approval of a need for booster doses in this population. SpikoGen® is a subunit recombinant...
8.
Ashrafi S, Pourahmad Kisomi P, Maroufizadeh S, Jabbari M, Nafar M, Samavat S, et al.
Int Urol Nephrol . 2022 Sep; 55(3):697-709. PMID: 36121573
Purpose: Concomitant kidney diseases raise the mortality rate due to the SARS-CoV-2 virus as an independent factor. Although a qualitative PCR test's result is sufficient for diagnosis, Cycle threshold value...
9.
Nafar M, Chehrazi S, Dalili N, Firouzan A, Poorrezagholi F, Samadian F, et al.
Transpl Infect Dis . 2022 Jan; 24(2):e13798. PMID: 35061293
Background: The mortality of coronavirus disease 2019 (COVID-19) is high in transplant patients, and effective vaccination is aimed to reduce severe disease and mortality. Methods: We conducted a cross-sectional study...
10.
Keshtkari S, Hajibaratali B, Mahjoob M, Dalili N, Samavat S, Ahmadpoor P, et al.
Iran J Kidney Dis . 2021 Dec; 15(6):441-450. PMID: 34930856
Introduction: Cardiovascular disease is considered as the main cause of mortality and morbidity in HD-patients and AS is a fundamental cause. This study was conducted to investigate whether intradialytic BP...